Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Nuclear Antigen antibody

This anti-Nuclear Antigen antibody is a Mouse Monoclonal antibody detecting Nuclear Antigen in FACS, IF, IHC and StM. Suitable for Human, Mouse and Rat.
Catalog No. ABIN6941371

Quick Overview for Nuclear Antigen antibody (ABIN6941371)

Target

See all Nuclear Antigen (IPO-38) Antibodies
Nuclear Antigen (IPO-38)

Reactivity

Human, Mouse, Rat

Host

  • 6
Mouse

Clonality

  • 6
Monoclonal

Conjugate

  • 6
This Nuclear Antigen antibody is un-conjugated

Application

  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (IHC), Staining Methods (StM)

Clone

SPM260
  • Immunogen

    Spleen cells of a patient with hairy cell leukemia

    Isotype

    IgM kappa
  • Application Notes

    Positive Control: Raji and PHA-stimulated (>12 hours) human or mouse lymphocytes. Breast and colorectal carcinomas.

    Known Application: Flow Cytometry (0.5-1 μg/million cells), Immunofluorescence (0.5-1 μg/mL), Immunohistochemistry (Formalin-fixed) (0.5-1.0 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    Nuclear Antigen (IPO-38)

    Alternative Name

    IPO-38 (Proliferation Marker)
You are here:
Chat with us!